1. Market Research
  2. > Biotechnology Market Trends
Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026

Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026

  • August 2016
  • 238 pages
  • ID: 4194701
  • Format: PDF
  • By Visiongain

Summary

Table of Contents

Report Details

Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026: Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine reviews the contract active pharmaceutical ingredient (API) manufacturing market for biologics. This study gives quantitative and qualitative analysis for that overall world market, as well as for countries and other submarkets, including the mammalian cell culture and microbial fermentation segments. This report assesses leading applications and significant developments within each, as well as drivers and restraints for them. Future trends that will affect the biotech API manufacturing services market are also examined. In addition, this study profiles leading contract manufacturing organisations (CMOs) in the outsourcing market and assesses their outlooks. Visiongain provides forecasts revenues for the period 2015 to 2026 for the biotech API manufacturing services market, as well as for therapeutic applications.

How this 238 page report delivers:

- Provides qualitative and quantitative analysis of the leading submarkets the period 2015-2026. Visiongain forecasts revenues and their growth for these submarkets:
- Mammalian cell culture
- Microbial fermentation
- Other expression platforms

- Provides qualitative and quantitative analysis of the leading contract API biological drug applications for the period 2015-2026. Visiongain forecasts contract API drug revenues to 2026 for these individual segments:
- Monoclonal antibody (mAb) therapies
- Vaccines
- Insulin therapies
- Interferon therapies
- Growth hormones

- Find forecasts of the leading therapeutic and national markets from 2015 to 2026:
- The EU, including the five leading markets (UK, Germany, France, Italy and Spain).
- The US
- Japan
- Switzerland
- Emerging markets such as the BRIC (Brazil, Russia, India, and China) countries, South Korea and Singapore.

- Profiles leading global and national companies that offer biotech API manufacturing services to the pharmaceutical industry. For each company, current services offered, recent developments and outlooks are discussed. Leading CMOs profiled in this chapter are:
- Boehringer Ingelheim BioXcellence
- Celltrion
- DSM Biologics
- Lonza
- Samsung BioLogics
- Cytovance Biologics
- Fujifilm Diosynth Biotechnologies
- Operations of leading biopharma companies, such as AbbVie, GSK and Novartis.

- Discover the regulatory outlook for biotech API manufacturing in leading regional and national markets in 2016, as well as predicted developments for the period to 2026.
- Read expert opinions from other authorities on the biotech API manufacturing industry.
- Identify important drug development and technology trends that will affect CMOs, their clients and other market participants from 2016. The report also contains SWOT and STEP analysis of the industry and market.
- Find profiles for leading CMOs offering biological drug API manufacturing services to pharmaceutical companies.

How This Report Delivers: Chapter Summary
This updated study provides an overview of the subject along with qualitative and quantitative analyses of the biotech API manufacturing services market. This report contains expert opinions from industry participants. In more detail, the chapters of this report contain the following information:

Chapter 1 forms a report overview.

Chapter 2 defines the biotech API manufacturing services market and provides an introduction to that industry.

Chapter 3 quantitatively assesses the world market for biotech API manufacturing services revenues. The chapter provides an estimate for the size of the market in 2015 and forecasts revenues for the period 2015-2026. Visiongain discusses the main drivers and restraints on the market for a 10-year forecast period.

Chapter 4 provides qualitative and quantitative analysis of the leading submarkets the period 2015-2026. Visiongain forecasts revenues and their growth for these submarkets:
- Mammalian cell culture
- Microbial fermentation
- Other expression platforms.

For the leading submarkets, we analyse commercial drivers and restraints, as well as forecasting revenues to 2026.

Chapter 5 provides qualitative and quantitative analysis of the leading contract API biological drug applications for the period 2015-2026. Visiongain forecasts contract API drug revenues to 2026 for these individual segments:
- Monoclonal antibody (mAb) therapies
- Vaccines
- Insulin therapies
- Interferon therapies
- Growth hormones.

Chapter 6 forecasts the leading national submarkets for biotech API manufacturing services, for the period 2015-2026. That section also provides quantitative analysis. The chapter offers a regional breakdown of the market by market share, and also discusses developments and future expectations for each main national submarket. National submarkets forecasted in this chapter are these:
- The EU, including the five leading markets (UK, Germany, France, Italy and Spain).
- The US
- Japan
- Switzerland
- Emerging markets such as the BRIC (Brazil, Russia, India, and China) countries, South Korea and Singapore.

Chapter 7 profiles leading global and national companies that offer biotech API manufacturing services to the pharmaceutical industry. For each company, current services offered, recent developments and outlooks are discussed. Leading CMOs profiled in this chapter are:
- Boehringer Ingelheim BioXcellence
- Celltrion
- DSM Biologics
- Lonza
- Samsung BioLogics
- Cytovance Biologics
- Fujifilm Diosynth Biotechnologies
- Operations of leading biopharma companies, such as AbbVie, GSK and Novartis.

Chapter 8 provides qualitative analysis of the biotech API manufacturing services market from 2015. That chapter identifies main strengths and weaknesses of the market, as well as opportunities and threats facing CMOs to 2026. Social, technological, economic and political (STEP) factors affecting market growth are also discussed. Industry trends and regulatory developments affecting the market are discussed.

Chapter 9 provides transcripts of interviews conducted by visiongain with other authorities. For this report, visiongain interviewed the following authorities on the CMO industry:
- Steve Bagshaw, CEO, Fujifilm Diosynth Biotechnologies, UK.
- Jon S. Gingrich, Manager of Business Development, Avid Bioservices Inc., US.

Chapter 10 summarises the report, highlighting conclusions from visiongain’s research and analysis.

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2020 Molecular Diagnostics Market: Supplier Shares, Sales Forecasts and Facilities by Country

2020 Molecular Diagnostics Market: Supplier Shares, Sales Forecasts and Facilities by Country

  • $ 3500
  • January 2020

This report provides:- Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA.- Estimates of facilities performing DNA sequencing and molecula ...

Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product, Application, Type, End User, Region - Global Forecast to 2024

Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product, Application, Type, End User, Region - Global Forecast to 2024

  • $ 4950
  • January 2020

The rising prevalence of infectious diseases and the introduction of newer pathogens, and the cost-benefits of INAAT is expected to drive the overall growth of the INAAT marketThe global isothermal nucleic ...

Global Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

Global Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

  • $ 2995
  • November 2019

The Global Antibody Partnering Terms and Agreements 2014 to 2019 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the ...


ref:plp2016

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on